Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1998 1
2006 1
2007 1
2008 1
2011 4
2012 1
2013 2
2015 2
2017 3
2018 3
2019 1
2020 2
2021 2
2022 1
2023 4
2024 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

27 results

Results by year

Filters applied: . Clear all
Page 1
Daratumumab plus Bortezomib, Melphalan, and Prednisone for Untreated Myeloma.
Mateos MV, Dimopoulos MA, Cavo M, Suzuki K, Jakubowiak A, Knop S, Doyen C, Lucio P, Nagy Z, Kaplan P, Pour L, Cook M, Grosicki S, Crepaldi A, Liberati AM, Campbell P, Shelekhova T, Yoon SS, Iosava G, Fujisaki T, Garg M, Chiu C, Wang J, Carson R, Crist W, Deraedt W, Nguyen H, Qi M, San-Miguel J; ALCYONE Trial Investigators. Mateos MV, et al. N Engl J Med. 2018 Feb 8;378(6):518-528. doi: 10.1056/NEJMoa1714678. Epub 2017 Dec 12. N Engl J Med. 2018. PMID: 29231133 Free article. Clinical Trial.
Biclonal myeloma in renal failure.
Nikolova-Vlahova MK, Kamburova M, Hristova J, Vasileiou D, Bogov B, Krasteva R, Hadjiev E, Tsvetkova G, Vasileva C, Houbanov N. Nikolova-Vlahova MK, et al. Among authors: hadjiev e. Cent Eur J Immunol. 2020;45(1):122-124. doi: 10.5114/ceji.2020.94714. Cent Eur J Immunol. 2020. PMID: 32425690 Free PMC article.
Calreticulin Mutations in Bulgarian MPN Patients.
Pavlov I, Hadjiev E, Alaikov T, Spassova S, Stoimenov A, Naumova E, Shivarov V, Ivanova M. Pavlov I, et al. Among authors: hadjiev e. Pathol Oncol Res. 2018 Jan;24(1):171-174. doi: 10.1007/s12253-017-0226-2. Epub 2017 Apr 14. Pathol Oncol Res. 2018. PMID: 28411309 Free article.
Clinical outcomes after 4.5 years of eliglustat therapy for Gaucher disease type 1: Phase 3 ENGAGE trial final results.
Mistry PK, Lukina E, Ben Turkia H, Shankar SP, Baris Feldman H, Ghosn M, Mehta A, Packman S, Lau H, Petakov M, Assouline S, Balwani M, Danda S, Hadjiev E, Ortega A, Foster MC, Gaemers SJM, Peterschmitt MJ. Mistry PK, et al. Among authors: hadjiev e. Am J Hematol. 2021 Sep 1;96(9):1156-1165. doi: 10.1002/ajh.26276. Epub 2021 Jul 11. Am J Hematol. 2021. PMID: 34161616 Free PMC article. Clinical Trial.
Probable HLA-mediated immunoediting of JAK2 V617F-driven oncogenesis.
Ivanova M, Tsvetkova G, Lukanov T, Stoimenov A, Hadjiev E, Shivarov V. Ivanova M, et al. Among authors: hadjiev e. Exp Hematol. 2020 Dec;92:75-88.e10. doi: 10.1016/j.exphem.2020.09.200. Epub 2020 Oct 2. Exp Hematol. 2020. PMID: 33017633 Free article.
Impact of venetoclax monotherapy on the quality of life of patients with relapsed or refractory chronic lymphocytic leukemia: results from the phase 3b VENICE II trial.
Cochrane T, Enrico A, Gomez-Almaguer D, Hadjiev E, Lech-Maranda E, Masszi T, Nikitin E, Robak T, Weinkove R, Wu SJ, Sail KR, Pesko J, Pai M, Komlosi V, Anderson MA. Cochrane T, et al. Among authors: hadjiev e. Leuk Lymphoma. 2022 Feb;63(2):304-314. doi: 10.1080/10428194.2021.1986217. Epub 2021 Oct 11. Leuk Lymphoma. 2022. PMID: 34632935 Clinical Trial.
Is There a Link Between Changes in Levels of Hepcidin and Stroke?
Petrova JJ, Manolov VE, Hadjidekova SP, Hadjiev EA, Bogov BI, Marinov BM, Vasilev VG, Tzatchev KN. Petrova JJ, et al. Among authors: hadjiev ea. Clin Lab. 2015;61(12):1935-9. doi: 10.7754/clin.lab.2015.150522. Clin Lab. 2015. PMID: 26882818
27 results